NTRB - Nutriband Inc. Stock Price, Fair Value and News

4.46USD-0.26 (-5.51%)Market Closed

Market Summary

USD4.46-0.26

Market Closed

-5.51%

NTRB Stock Price

View Fullscreen

NTRB RSI Chart

NTRB Valuation

Market Cap

48.9M

Price/Earnings (Trailing)

-8.92

Price/Sales (Trailing)

23.46

EV/EBITDA

-9.33

Price/Free Cashflow

-13.67

NTRB Price/Sales (Trailing)

NTRB Profitability

Operating Margin

41.34%

EBT Margin

-263.04%

Return on Equity

-85.2%

Return on Assets

-72.97%

Free Cashflow Yield

-7.32%

NTRB Fundamentals

NTRB Revenue

Revenue (TTM)

2.1M

NTRB Earnings

Earnings (TTM)

-5.5M

Earnings Growth (Yr)

-12.01%

Earnings Growth (Qtr)

-6.88%

Breaking Down NTRB Revenue

Last 7 days

32.7%

Last 30 days

4.5%

Last 90 days

80.6%

Trailing 12 Months

-3.3%

How does NTRB drawdown profile look like?

NTRB Financial Health

Current Ratio

1.02

NTRB Investor Care

Shares Dilution (1Y)

40.04%

Diluted EPS (TTM)

-0.69

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.1M	0	0	0
2023	2.1M	2.1M	2.1M	2.1M
2022	1.4M	1.5M	1.7M	2.0M
2021	943.7K	1.3M	1.4M	1.3M
2020	370.6K	296.4K	306.0K	615.2K
2019	245.3K	276.6K	308.0K	339.3K
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Nutriband Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 06, 2023	melnik serguei	gifted	-	-	-5,000	chairman and president
Jun 15, 2022	sheridan gareth	gifted	-	-	-10,000	ceo
May 10, 2022	sheridan gareth	acquired	38,000	3.8	10,000	ceo
Feb 24, 2022	melnik serguei	bought	2,015	4.03	500	chairman and president
Feb 24, 2022	melnik serguei	bought	-20,150	4.03	-5,000	chairman and president
Feb 06, 2022	melnik serguei	gifted	-	-	-10,000	chairman and president
Jan 05, 2021	sheridan gareth	acquired	150,000	15.00	10,000	ceo
May 30, 2019	melnik serguei	gifted	-	-	-20,000	cfo
Jan 10, 2019	goodman gerald	acquired	-	-	26,250	chief financial officer
Jul 31, 2018	davidov michael	acquired	-	-	5,000	-

Which funds bought or sold NTRB recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	STATE STREET CORP	unchanged	-	37,812	78,042	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	added	150	54.00	68.00	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-0.55	6,695	13,836	-%
May 15, 2024	Royal Bank of Canada	added	40,667	158,000	158,000	-%
May 15, 2024	CITADEL ADVISORS LLC	added	350	81,508	90,551	-%
May 14, 2024	Farther Finance Advisors, LLC	new	-	56,793	56,793	-%
May 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	unchanged	-	128,297	264,790	-%
May 13, 2024	Atria Wealth Solutions, Inc.	unchanged	-	24,055	49,422	-%
May 13, 2024	CLEAR STREET LLC	added	647	3,000	3,000	-%
May 13, 2024	UBS Group AG	sold off	-100	-1,856	-	-%

Are Funds Buying or Selling NTRB?

Are funds buying NTRB calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NTRB

No. of Funds

Unveiling Nutriband Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	melnik serguei	9.26%	820,418	SC 13G
Feb 12, 2024	sheridan gareth	19.88%	1,761,667	SC 13G
Jan 23, 2024	t.i.i. - jetservices, lda	15.92%	1,347,524	SC 13D

Recent SEC filings of Nutriband Inc.

View All Filings

Date Filed	Form Type	Document
May 17, 2024	8-K	Current Report
May 01, 2024	NT 10-K	NT 10-K
May 01, 2024	10-K	Annual Report
Apr 23, 2024	8-K	Current Report
Mar 28, 2024	8-K	Current Report
Mar 25, 2024	5	Insider Trading
Mar 25, 2024	5	Insider Trading
Mar 25, 2024	5	Insider Trading
Feb 13, 2024	SC 13G	Major Ownership Report
Feb 12, 2024	SC 13G	Major Ownership Report

Peers (Alternatives to Nutriband Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	234.45%	75.34%	-4.58	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Nutriband Inc. News

Latest updates

Nutriband Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-	-	-	-	476,932	527,535	618,003	456,149	477,922	491,890	283,037	213,739	433,488	348,091	391,797	84,450	119,364	19,577	82,567	74,913	193,590	178,203
Cost Of Revenue	27.7%	343,385	268,920	356,256	254,648	398,139	349,272	304,353	277,436	300,312	207,700	214,455	195,610	206,730	228,772	116,937	74,939	126,228	106,126	117,959	198,794	-
Costs and Expenses	-14.9%	1,830,962	2,151,352	1,480,116	1,494,810	2,211,076	1,689,522	1,490,395	1,163,801	4,267,426	1,821,478	695,981	747,552	2,529,775	432,748	310,268	266,856	635,670	413,141	524,525	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	266,856	635,670	413,141	524,525	766,751	598,220
S&GA Expenses	-30.6%	924,207	1,330,929	678,738	839,732	1,189,785	1,049,532	908,173	768,551	1,535,896	1,452,778	481,526	551,942	2,323,045	203,976	193,331	191,917	509,442	307,015	406,566	567,957	516,202
R&D Expenses	2.2%	563,370	551,503	445,122	400,430	295,826	290,718	277,869	117,814	-	161,000	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	-4.9%	-2.49	-2.37	-2.05	-2.15	-1.99	-3.05	-3.93	-4.20	-4.04	-3.25	-1.94	-1.99	-	-	-	-	-	-	-	-	-
Interest Expenses	-217.2%	-47,131	40,200	9,235	3,166	-4,216	3,966	4,429	4,110	3,153	33,380	41,019	40,869	73,850	1,618	51.00	205,167	71,854	414	953	192	-
Earnings Before Taxes	-6.9%	-1,880,966	-1,759,946	-829,173	-1,015,229	-1,679,325	-1,075,485	-1,038,675	-689,989	-3,768,875	-1,571,821	-519,923	-315,057	-2,252,196	-42,569	-225,869	-412,194	-944,435	-753,274	-450,565	-573,353	-515,750
EBT Margin	-3.7%	-2.63	-2.54	-2.21	-2.31	-2.16	-3.22	-4.14	-4.47	-4.34	-3.64	-2.26	-2.25	-	-	-	-	-	-	-	-	-
Net Income	-6.9%	-1,880,966	-1,759,946	-829,173	-1,015,229	-1,679,325	-1,075,485	-1,038,675	-689,989	-3,768,425	-1,571,821	-519,923	-315,957	-2,252,196	-42,569	-225,869	-412,194	-944,435	-753,274	-450,565	-573,353	-515,750
Net Income Margin	-3.7%	-2.63	-2.54	-2.21	-2.31	-2.16	-3.22	-4.14	-4.47	-4.34	-3.65	-2.26	-2.26	-	-	-	-	-	-	-	-	-
Free Cashflow	27.9%	-767,377	-1,064,270	-995,135	-752,488	-824,028	-521,715	-932,699	-788,060	-1,262,641	-1,210,837	-99,146	-318,194	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-11.8%	7,517	8,523	9,873	8,676	9,456	10,669	11,387	11,984	12,740	15,428	10,164	10,560	9,927	10,080	2,199	2,198	2,198	2,441	2,353	2,519	2,808
Current Assets	-48.9%	1,022	2,000	3,274	1,993	2,694	3,507	4,114	4,642	5,465	5,949	607	934	314	323	90.00	67.00	43.00	263	153	315	590
Cash Equivalents	-61.0%	493	1,265	2,335	1,278	1,985	2,816	3,345	4,011	4,892	5,485	304	411	152	193	39.00	21.00	10.00	97.00	14.00	202	475
Inventory	-3.5%	169	175	157	181	229	184	162	128	132	125	73.00	90.00	53.00	39.00	-	-	-	-	-	-	-
Net PPE	1.1%	775	767	806	853	898	934	979	1,001	979	990	1,035	1,072	1,077	1,282	93.00	102	111	120	129	137	146
Goodwill	0%	5,022	5,022	5,022	5,022	5,022	5,349	5,349	5,349	5,349	7,530	7,530	7,530	7,530	8,187	1,719	1,719	1,719	1,719	1,719	1,719	1,719
Liabilities	-61.6%	1,079	2,812	2,982	956	883	938	985	904	880	1,109	2,847	2,724	2,815	2,826	903	1,462	2,022	-	-	-	-
Current Liabilities	39.2%	999	718	874	784	749	790	804	723	779	1,004	2,656	2,522	2,569	2,554	868	726	2,022	1,368	720	435	403
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	68.00	-	-	-	-
Shareholder's Equity	12.7%	6,438	5,711	6,891	7,720	8,573	9,732	10,402	11,080	11,859	14,319	7,316	7,836	7,112	7,254	1,297	1,473	175	1,073	1,633	2,084	2,405
Retained Earnings	-7.2%	-27,980	-26,099	-24,339	-23,509	-22,494	-20,815	-19,739	-18,701	-18,011	-14,242	-12,670	-12,151	-11,835	-9,582	-9,540	-9,314	-8,902	-7,957	-7,204	-6,754	-6,180
Additional Paid-In Capital	8.2%	34,442	31,836	31,255	31,255	31,093	30,670	30,264	29,967	29,966	28,487	19,981	19,981	18,871	16,831	10,832	10,782	9,073	9,026	8,833	8,816	8,580
Shares Outstanding	13.1%	8,860	7,833	7,833	7,833	7,833	8,660	8,409	9,183	9,155	7,589	7,416	7,411	7,295	-	-	-	-	-	-	-	-
Float	-	-	-	17,131	-	-	-	21,711	-	-	-	33,327	-	-	-	32,762	-	-	-	97,425	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	32.5%	-718	-1,064	-995	-749	-814	-520	-908	-744	-1,232	-1,208	-88.53	-279	-83.15	100	-112	-201	-117	-266	-238	-272	-282
Share Based Compensation	-100.0%	-	338	87.00	75.00	327	-	-	-	-221	529	98.00	128	1,955	12.00	-	-	-	-	-	253	-
Cashflow From Investing	-Infinity%	-49.14	-	-	-2.62	-10.02	-1.27	-24.21	-43.80	-30.21	-1.99	-10.62	-38.78	-	-	-	-	-	-	-	-	-
Cashflow From Financing	-0.9%	-5.00	-4.96	2,052	45.00	-6.85	-6.52	267	-93.16	669	6,392	-7.35	577	42.00	-12.59	131	212	30.00	350	-	-	500
Buy Backs	-	-	-	-	-	-240*	5*	-29.58	-89.20	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NTRB Income Statement

2024-01-31

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
Revenue	$ 2,085,314	$ 2,079,609
Costs and expenses:
Cost of revenues	1,223,209	1,329,200
Research and development	1,960,425	982,227
Goodwill impairment		327,326
Selling, general and administrative	3,773,606	3,916,041
Total Costs and Expenses	6,957,240	6,554,794
Loss from operations	(4,871,926)	(4,475,185)
Other income (expense):
Interest income	16,850
Loss on extinguishment of debt	(554,423)
Interest expense	(75,815)	(8,289)
Total other income (expense)	(613,388)	(8,289)
Loss before provision for income taxes	(5,485,314)	(4,483,474)
Provision for income taxes
Net loss	$ (5,485,314)	$ (4,483,474)
Net loss per share of common stock-basic (in Dollars per share)	$ (0.69)	$ (0.53)
Weighted average shares of common stock outstanding - basic (in Shares)	7,954,105	8,459,547

NTRB Balance Sheet

2024-01-31

Condensed Consolidated Balance Sheets - USD ($)	Jan. 31, 2024	Jan. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 492,942	$ 1,985,440
Accounts receivable	148,649	113,045
Inventory	168,605	229,335
Prepaid expenses	211,667	365,925
Total Current Assets	1,021,863	2,693,745
PROPERTY & EQUIPMENT-net	774,924	897,735
OTHER ASSETS:
Goodwill	5,021,713	5,021,713
Operating lease right of use asset	31,374	62,754
Intangible assets-net	667,280	780,430
TOTAL ASSETS	7,517,154	9,456,377
CURRENT LIABILITIES:
Accounts payable and accrued expenses	680,132	534,679
Deferred revenue	157,502	162,903
Operating lease liability-current portion	34,276	31,291
Notes payable-current portion	127,183	19,740
Total Current Liabilities	999,093	748,613
LONG-TERM LIABILITIES:
Note payable-net of current portion	79,826	100,497
Operating lease liability-net of current portion		34,277
Total Liabilities	1,078,919	883,387
Commitments and Contingencies
STOCKHOLDERS’ EQUITY:
Preferred stock, $.001 par value, 10,000,000 shares authorized, -0- outstanding
Common stock, $.001 par value, 291,666,666 shares authorized; 8,869,870 and 7,843,150 shares issued at January 31,2024 and 2023, respectively, 8,859,870 and 7,833,150 shares outstanding as of January 31, 2024 and 2023, respectively	8,860	7,833
Additional paid-in-capital	34,442,339	31,092,807
Accumulated other comprehensive loss	(304)	(304)
Treasury stock, 10,000 and 10,000 shares at cost, respectively	(32,641)	(32,641)
Accumulated deficit	(27,980,019)	(22,494,705)
Total Stockholders’ Equity	6,438,235	8,572,990
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	7,517,154	9,456,377
Related Party
LONG-TERM LIABILITIES:
Note payable-related party

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

CEO	Mr. Gareth Sheridan
WEBSITE	https://nutriband.com
INDUSTRY	Biotechnology

Nutriband Inc. Frequently Asked Questions

What is the ticker symbol for Nutriband Inc.? What does NTRB stand for in stocks?

NTRB is the stock ticker symbol of Nutriband Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nutriband Inc. (NTRB)?

As of Fri May 17 2024, market cap of Nutriband Inc. is 48.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NTRB stock?

You can check NTRB's fair value in chart for subscribers.

What is the fair value of NTRB stock?

You can check NTRB's fair value in chart for subscribers. The fair value of Nutriband Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nutriband Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NTRB so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nutriband Inc. a good stock to buy?

The fair value guage provides a quick view whether NTRB is over valued or under valued. Whether Nutriband Inc. is cheap or expensive depends on the assumptions which impact Nutriband Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NTRB.

What is Nutriband Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NTRB's PE ratio (Price to Earnings) is -8.92 and Price to Sales (PS) ratio is 23.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NTRB PE ratio will change depending on the future growth rate expectations of investors.